Filtros de búsqueda

Lista de obras de Sam Schulman

6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII

artículo científico publicado en 2008

A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery.

artículo científico publicado en 2011

A comparative randomized trial of low-dose versus high-dose streptokinase in deep vein thrombosis of the thigh

scientific article published on 01 April 1984

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group

artículo científico publicado en 1995

A molecular genetic study of factor XI deficiency

artículo científico publicado en 1991

A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery

artículo científico publicado en 2010

A randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders

artículo científico publicado en 2002

A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I.

artículo científico publicado en 2003

A therapeutic alternative for haemophiliacs with inhibitors

artículo científico publicado el 1 de junio de 1992

Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study

artículo científico publicado en 2012

Acquired hemophilia masked by warfarin therapy: report on two cases

artículo científico publicado en 2003

Acquired platelet dysfunction may be an aetiologic factor in Heyde's syndrome--normalization of bleeding time after aortic valve replacement

artículo científico publicado en 2002

Activated prothrombin complex concentrate for dabigatran-associated bleeding.

artículo científico publicado en 2013

Acute effects with reference to thrombogenicity and liver toxicity after injection of different coagulation factor concentrates

artículo científico publicado en 1989

Adherence to anticoagulant treatment with dabigatran in a real-world setting

scientific article published on 01 July 2013

Adjusted dose continuous infusion of factor VIII in patients with haemophilia A.

artículo científico publicado en 1992

Advances in the management of venous thromboembolism.

artículo científico publicado en 2012

Advantages and limitations of the new anticoagulants

artículo científico

An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency.

artículo científico publicado en 2006

Antibodies against hepatitis C in a population of Swedish haemophiliacs and heterosexual partners

artículo científico publicado en 1990

Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group

artículo científico publicado en 1998

Anticoagulation Control with Daily Low‐Dose Vitamin K to Reduce Clinically Adverse Outcomes and International Normalized Ratio Variability: A Systematic Review and Meta‐Analysis ⬇️

artículo científico publicado el 6 de junio de 2013

Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery

artículo científico publicado en 2015

Anticoagulation in venous thrombosis

artículo científico publicado en 1996

Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion

scholarly article by Sam Schulman et al published April 2013 in Thrombosis Research

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations

artículo científico publicado en 2008

Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity

artículo científico publicado en 1992

Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding.

artículo científico publicado en 2010

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry

artículo científico publicado en 2013

Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH

artículo científico publicado en 2015

Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes

artículo científico publicado en 2014

Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach

artículo científico publicado en 2013

Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time

artículo científico publicado en 2018

Bile acids and coagulation factors: paradoxical association in children with chronic liver disease

artículo científico publicado en 2013

Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis

artículo científico publicado el 13 de mayo de 2013

Bleeding and antidotes in new oral anticoagulants.

artículo científico

Bleeding events with dabigatran or warfarin in patients with venous thromboembolism

artículo científico publicado en 2015

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

scientific article published on 15 April 2020

Can fondaparinux safely prevent the occurrence of venous thromboembolism in acutely ill medical patients?

artículo científico publicado en 2006

Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical events in a retrospective cohort

artículo científico publicado en 2022

Centralized care is the basis of care programs for hemophilia patients

artículo científico publicado en 1999

Cervical artery dissection: pathology, epidemiology and management

artículo científico publicado en 2009

Characteristics of septic arthritis in human immunodeficiency virus-infected haemophiliacs versus other risk groups.

artículo científico publicado en 1999

Clinical experience with the new oral anticoagulants for treatment of venous thromboembolism

artículo científico

Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study

artículo científico publicado en 2008

Clinical factors influencing the sensitivity to warfarin when restarted after surgery

artículo científico publicado en 2008

Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry.

artículo científico publicado en 2016

Clinical practice. Care of patients receiving long-term anticoagulant therapy.

artículo científico publicado en 2003

Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices

artículo científico publicado en 2014

Coagulation factor concentrates by continuous infusion

artículo científico publicado en 1997

Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?

artículo científico publicado en 2012

Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial

artículo científico publicado en 2013

Confusion around the official classification of arthropathy

artículo científico publicado en 2007

Continuous infusion instead of bolus injections of factor concentrate?

artículo científico publicado en 1996

Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience

artículo científico publicado en 2004

Continuous infusion of factor concentrates: review of use in hemophilia A and demonstration of safety and efficacy in hemophilia B.

artículo científico publicado en 1995

Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII

scientific article published on 01 December 2005

Continuous infusion.

artículo científico publicado en 2003

Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B.

artículo científico publicado en 2003

Coping style in relation to the consumption of factor concentrate in HIV-infected hemophiliacs during the years after their infection became known

artículo científico publicado en 1994

Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden

artículo científico publicado en 2004

Cure of hemophilia is approaching. Gene therapy is the hope

artículo científico publicado el 28 de noviembre de 2001

Current strategies in prophylaxis and treatment of venous thromboembolism.

artículo científico publicado en 2008

Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus

scientific article published on 01 September 1996

D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study

artículo científico publicado en 2015

DDAVP--the multipotent drug in patients with coagulopathies.

artículo científico publicado en 1991

Dabigatran etexilate: future directions in anticoagulant treatment.

scientific article published on 13 August 2009

Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing.

artículo científico publicado en 2009

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.

artículo científico publicado en 2015

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

artículo científico publicado en 2005

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.

scientific article published on 30 October 2009

Design and assessment of clinical trials on continuous infusion

artículo científico publicado en 1996

Desmopressin--an effective agent in many hemorrhagic disorders

artículo científico publicado en 1992

Determinants of bleeding risk in patients on antithrombotic and antifibrinolytic drugs.

artículo científico publicado en 2008

Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation

artículo científico publicado en 2016

Difficulties in obtaining financial support for studies of hemorrhage during treatment with anticoagulants

artículo científico publicado en 1989

Direct and indirect costs of management of long-term warfarin therapy in Canada

artículo científico publicado en 2010

Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

artículo científico

Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?

artículo científico publicado en 2002

Distal deep vein thrombosis--a benign disease?

artículo científico publicado en 2014

Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?

artículo científico publicado en 2004

Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study

artículo científico publicado en 2009

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis.

artículo científico publicado en 2006

Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients

artículo científico publicado en 2014

Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure

artículo científico publicado en 2015

Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events

artículo científico publicado en 2016

Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery

artículo científico publicado en 1999

Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

scientific article published on 06 October 2014

Elimination of antibodies against coagulation factor VIII: Factor VIIa is the most promising therapeutic alternative

scientific article published on 01 January 1989

Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials

artículo científico publicado en 2010

Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis

scientific article published on 01 January 2006

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolism.

artículo científico publicado en 2002

Experiences with continuous infusion of recombinant activated factor VII.

artículo científico publicado en 1998

Extended Anticoagulation in Venous Thromboembolism ⬇️

artículo científico publicado el 13 de junio de 2013

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism

artículo científico publicado en 2013

Extension of anticoagulation after venous thromboembolism - risk factors influencing the decision.

artículo científico publicado en 2008

Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia

scientific article published on 01 April 1985

False negative result by the wellcozyme anti-HIV assay in testing an HIV positive haemophiliac

artículo científico publicado en 1987

Feasibility of using recombinant factor VIIa in continuous infusion.

artículo científico publicado en 1996

Fibrin sealant in surgery of patients with a hemorrhagic diathesis

scientific article published on 01 July 1995

Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series

artículo científico publicado en 2011

For how long should the treatment with vitamin K antagonists be maintained?

scientific article published on 01 December 1999

Getting intimate with the venous thrombus

artículo científico publicado en 2009

Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial

artículo científico publicado en 2014

HIV infection in a defined population of Swedish haemophiliacs

artículo científico publicado en 1987

HIV isolation and antigen detection in infected individuals and their seronegative sexual partners.

artículo científico publicado en 1988

HIV-serology and lymphocyte subsets in relation to therapy and clinical development in haemophiliacs.

artículo científico publicado en 1988

Haemostatic and replacement therapy in von Willebrand disease

artículo científico publicado en 1999

Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding

scientific article published on 02 August 2019

Helicobacter pylori causes gastrointestinal hemorrhage in patients with congenital bleeding disorders.

artículo científico publicado en 2003

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

artículo científico publicado en 2008

Heparin, DDAVP and the bleeding time

scientific article published on 01 March 1991

Hepatitis C virus-infected, HCV-RNA-negative patients with bleeding disorders--relationship to age, HIV and treatment

artículo científico publicado en 1998

Hepatitis E virus infection in hemophiliacs

artículo científico publicado en 1995

Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.

artículo científico publicado en 1984

High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients.

artículo científico publicado en 2013

High versus ultra-high purity factor VIII concentrate therapy: prospective evaluation of immunological and clinical parameters in HIV seronegative and seropositive hemophiliacs

artículo científico publicado en 1994

Home therapy with continuous infusion of factor VIII after minor surgery or serious haemorrhage

artículo científico publicado en 1996

How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy

artículo científico publicado en 2017

How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch ⬇️

artículo científico publicado el 29 de marzo de 2012

Hypercoagulability in Multiple Myeloma and Its Precursor State, Monoclonal Gammopathy of Undetermined Significance ⬇️

artículo científico publicado el 1 de enero de 2011

Hypercoagulability preceding cancer. Are anticoagulants also antineoplastic?

artículo científico publicado en 2005

Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients

artículo científico publicado en 1991

Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy

artículo científico publicado en 2002

Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up.

artículo científico publicado en 1987

Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model ⬇️

artículo científico publicado el 10 de noviembre de 2010

Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study

artículo científico publicado en 2016

Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial

artículo científico publicado en 2000

Increased fetal loss in women with heritable thrombophilia.

artículo científico publicado en 1996

Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome

artículo científico publicado en 2015

Influence of changes in lifestyle on fibrinolytic parameters and recurrence rate in patients with venous thromboembolism

scientific article published on 01 June 1995

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials

artículo científico publicado en 2011

Inhibition of warfarin activity by ribavirin

artículo científico publicado en 2002

Intensive initial oral anticoagulation and shorter heparin treatment in deep vein thrombosis

artículo científico publicado en 1984

Is 3 months the optimum duration of anticoagulation therapy for deep vein thrombosis and pulmonary embolism?

scientific article published on 19 June 2007

Is the network meta-analysis (NETMA) bringing us closer to the truth? Insights from recent antithrombotic drug data ⬇️

artículo científico publicado el 10 de octubre de 2012

Is the warfarin saga over? ⬇️

artículo científico publicado el 1 de marzo de 2012

Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity

artículo científico publicado en 2007

Less menorrhagia for women with VTE.

artículo científico publicado en 2016

Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus

artículo científico publicado en 2003

Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial

artículo científico publicado en 2014

Local venous infusion of streptokinase in DVT

scientific article published on 01 May 1984

Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.

artículo científico publicado en 2015

Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase

artículo científico publicado en 1986

Low PAI-1 activity in relation to inflammatory parameters, insulin profile and body mass index

artículo científico publicado en 2008

Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate

artículo científico publicado en 2006

Low-intensity warfarin therapy prevented recurrent venous thromboembolism

scientific article published on 01 September 2003

Major surgery seems not to influence HIV disease progression in haemophilia patients

artículo científico publicado en 1998

Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study

scientific article published on 10 July 2012

Management of bleeding complications in patients with cancer on DOACs

artículo científico publicado en 2016

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis

Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report

artículo científico publicado en 2015

Management of recurrent venous thromboembolism in patients with cancer: A review

artículo científico publicado en 2018

Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Minimizing factor requirements for surgery without increased risk.

artículo científico publicado en 2004

Modification of von Willebrand disease after liver transplantation

artículo científico publicado en 2001

Molecular genetic analysis of severe protein C deficiency

article

Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience.

artículo científico publicado en 1994

Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate

artículo científico publicado en 2013

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.

artículo científico publicado en 2015

Multifocal pseudotumour in a single limb

artículo científico publicado en 1997

Multiple joint procedures in a single operative session on hemophilic patients.

artículo científico publicado en 1996

NXY-059 does not affect bleeding time in healthy volunteers: a randomized, double-blind, placebo-controlled, 3-period crossover phase I study

artículo científico publicado en 2007

New anticoagulants in atrial fibrillation management.

artículo científico

New aspects on treatment modalities for thromboembolic episodes.

artículo científico publicado en 2010

New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism

scientific article published on 01 September 2006

New oral anticoagulant agents - general features and outcomes in subsets of patients

artículo científico publicado en 2014

No evidence for vertical transmission in children born to HIV seropositive male haemophiliacs

artículo científico publicado en 1988

Novel anticoagulant agents: introduction

artículo científico publicado en 2003

On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome

artículo científico publicado en 2003

Optimal Duration of Anticoagulant Therapy ⬇️

artículo científico publicado el 5 de febrero de 2013

Optimal duration of oral anticoagulant therapy in venous thromboembolism

scientific article published on 01 July 1997

Optimal reversal of vitamin K antagonists

scientific article published on 28 November 2005

Optimal timing of resumption of warfarin after intracranial hemorrhage

artículo científico publicado en 2010

Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: A survey of Canadian spine surgeons

artículo científico publicado en 2017

Optimization of treatment for venous thromboembolism and prevention of recurrences.

artículo científico publicado en 1999

Oral surgery in patients with hereditary bleeding disorders. A survey of treatment in the Stockholm area (1974-1985)

artículo científico publicado en 1989

Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study

artículo científico publicado en 2010

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial

artículo científico publicado en 2009

Partial expression of GP Ib measured by flow cytometry in two patients with Bernard-Soulier syndrome

artículo científico publicado en 1994

Patient self-management of anticoagulants reduced arterial thromboembolism and adverse effects

scientific article published on 01 July 2005

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

scientific article published on 22 June 2015

Perioperative Management of Dabigatran: A Prospective Cohort Study

artículo científico publicado en 2015

Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.

artículo científico publicado en 2008

Periprocedural Management of Direct Oral Anticoagulants: Comment on the 2015 American Society of Regional Anesthesia and Pain Medicine Guidelines

artículo científico publicado en 2016

Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy ⬇️

artículo científico publicado el 1 de abril de 2012

Pharmacokinetic properties of two factor VIII concentrates with single and double viral inactivation

artículo científico publicado en 1996

Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosis

artículo científico publicado en 2005

Pharmacologic tools to reduce bleeding in surgery

artículo científico publicado el 1 de enero de 2012

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

artículo científico publicado en 2020

Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins

artículo científico publicado en 2003

Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months

artículo científico publicado en 2006

Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators

artículo científico publicado en 2009

Potential antidotes for reversal of old and new oral anticoagulants

artículo científico

Pregnancy, heparin and osteoporosis

artículo científico publicado en 2002

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention

artículo científico publicado en 2009

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

artículo científico publicado en 1999

Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran

artículo científico publicado en 2005

Protein C deficiency and thromboembolism: recurrent mutation at Arg 306 in the protein C gene

article

Prothromplex in stead of Beriplex P/N as acute antidote against warfarin

artículo científico publicado en 2001

Psychosocial self-prognosis in relation to mortality and morbidity in hemophiliacs with HIV infection

artículo científico publicado en 1994

Pulmonary hypertension in hemophilia

artículo científico publicado en 1988

Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study Group

scientific article published on 01 August 1994

Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy

artículo científico publicado en 2012

Rapid quantitativeD-dimer to exclude pulmonary embolism: a prospective cohort management study

artículo científico publicado en 2016

Real-world variability in dabigatran levels in patients with atrial fibrillation

artículo científico publicado en 2015

Recombinant FVIIa in children with liver disease.

artículo científico publicado en 2005

Recombinant factor VIIa in multiple surgery

scientific article published on 01 January 1994

Recommendations on biosimilar low-molecular-weight heparins

artículo científico publicado en 2009

Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis.

artículo científico publicado en 2015

Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.

artículo científico

Relationship between thromboembolic complications and intensity of treatment during long-term prophylaxis with oral anticoagulants following DVT

scientific article published on 01 February 1985

Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban

artículo científico publicado en 2012

Respiratory review of 2013: pulmonary thromboembolism

artículo científico publicado en 2013

Response to Dr Junqueira

artículo científico publicado en 2013

Response to letter regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin"

artículo científico publicado en 2014

Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: no

artículo científico publicado el 3 de noviembre de 2011

Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study

artículo científico publicado en 2017

Review of pumps for continuous infusion of coagulation factor concentrates: what are the options?

artículo científico publicado en 1996

Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism

artículo científico publicado en 2006

Rivaroxaban in orthopedic surgery--a change of paradigm?

scientific article published on 10 August 2009

Role of fibrin sealants in surgical procedures on patients with hemostatic disorders.

artículo científico publicado en 1996

Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease

scientific article published on 01 February 1999

Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis

artículo científico publicado en 2013

Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group

artículo científico publicado en 1998

Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects

artículo científico publicado en 2006

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran ⬇️

artículo científico publicado el 30 de octubre de 2003

Secondary prevention of venous thromboembolism

artículo científico publicado en 2013

Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial

artículo científico publicado en 2013

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis

artículo científico publicado en 2014

Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation: a meta-analysis?

artículo científico publicado en 2012

Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range.

artículo científico publicado en 2009

Social support and the development of immune function in human immunodeficiency virus infection

artículo científico publicado en 1995

Stability of factor VIII concentrates after reconstitution

artículo científico publicado en 1994

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy

artículo científico publicado en 1988

Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis

artículo científico publicado en 2013

Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants

artículo científico publicado en 2014

The Oral Thrombin Inhibitor Dabigatran: Strengths and Weaknesses ⬇️

artículo científico publicado el 7 de febrero de 2012

The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal

artículo científico publicado en 2013

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group

artículo científico publicado en 1997

The duration of oral anticoagulation after deep vein thrombosis. A randomized study

scientific article published on 01 January 1985

The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group

scientific article published on 01 January 1999

The feasibility of using concentrates containing factor IX for continuous infusion

artículo científico publicado en 1995

The fixed flexed and subluxed knee in the haemophilic child: what should be done?

artículo científico publicado en 1996

The onerous task of comparing treatments in inhibitor patients

artículo científico publicado en 2007

The plasma concentration of activated protein C appears normal in patients with haemophilia

artículo científico publicado en 2009

The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism

artículo científico publicado en 2007

The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg. The DURAC Trial Study Group

artículo científico publicado en 2000

The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation

scientific article published on 01 May 1999

The role of ximelagatran in the treatment of venous thromboembolism

artículo científico publicado en 2005

The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group

artículo científico publicado en 1996

There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis

artículo científico publicado en 2003

Thermography in the diagnosis of DVT

scientific article published on 01 October 1981

Thrombin generation test in children and adolescents with chronic liver disease

artículo científico publicado en 2014

Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy

artículo científico publicado en 2011

Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis

artículo científico publicado en 1985

Thrombophilia and location of venous thromboembolism

artículo científico publicado en 2007

Thrombophilic polymorphism--a short-term or long-term risk for recurrence?

artículo científico publicado en 2008

Thromboprophylaxis in medical patients--why not for all?

artículo científico publicado en 2006

Thrombosis in inherited factor VII deficiency

artículo científico publicado en 2003

Thrombosis is associated with inferior survival in multiple myeloma ⬇️

artículo científico publicado el 17 de abril de 2012

Thrombotic complications after substitution with a FVII concentrate

scientific article published on 01 November 1991

Tossing a coin or using common sense ⬇️

artículo científico publicado el 1 de marzo de 2013

Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia A.

artículo científico publicado en 2001

Transmission of HIV infection to heterosexual partners but not to household contacts of seropositive haemophiliacs

artículo científico publicado en 1986

Transmission of hepatitis C with pasteurised factor VIII.

artículo científico publicado en 1992

Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Treatment of bleeding complications in patients on anticoagulant therapy

artículo científico publicado en 2018

Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III.

artículo científico publicado en 1992

Treatment of venous thromboembolism with dabigatran.

artículo científico

Treatment of venous thromboembolism with new oral anticoagulants according to patient risk.

artículo científico publicado en 2015

Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer

artículo científico publicado en 2015

Two different missense mutations at Arg 178 of the protein C (PROC) gene causing recurrent venous thrombosis

artículo científico publicado en 1992

Validation of a composite score for clinical severity of hemophilia

artículo científico publicado en 2008

Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation

artículo científico publicado en 2013

Venous thromboembolism in older adults: A community-based study

artículo científico publicado en 2014

Vitamin K antagonists and cancer: rebuttal

artículo científico publicado en 2004

Von Willebrand disease: an update in the Aland islands

artículo científico publicado en 1999

Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial

artículo científico publicado en 2011

Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis.

artículo científico publicado en 2017

When is it safe to stop for safety?

scientific article published on 01 June 2012

When the rubber meets the road: adherence and persistence with non-vitamin K antagonist oral anticoagulants and old oral anticoagulants in the real world-a problem or a myth ?

artículo científico publicado en 2014

Ximelagatran for the secondary prevention of venous thromboembolism: a complementary follow-up analysis of the THRIVE III study

artículo científico publicado en 2005

[Bleeding time--only in special cases. The method is of little value as a general screening analysis]

artículo científico publicado en 2008

[Hereditary thrombogenic defects in the national family registry]

scientific article published on 01 April 1987

[Increased risk of thrombosis in FXII deficiency?]

scientific article published on 01 February 1995

[Length of treatment in deep venous thrombosis--some comments]

artículo científico publicado en 2000

[Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer]

artículo científico publicado en 2004

[New preparations for coagulation disorders]

artículo científico publicado en 1992

[Venous thromboembolism, warfarin and cancer--a well-known connection]

scientific article published on 01 October 2000

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda